Real‐world experience of using mogamulizumab in relapsed/refractory mycosis fungoides/Sézary syndrome
Author:
Affiliation:
1. University Hospital Birmingham Birmingham UK
2. Hospital 12 de Octubre. Institute i+12. CIBERONC. Medical School University Complutense Madrid Spain
Publisher
Wiley
Subject
Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19720
Reference8 articles.
1. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
2. Primary Sézary Syndrome Commonly Shows Low-Grade Cytologic Atypia and an Absence of Epidermotropism
3. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
4. Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?
5. Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review;Journal of the European Academy of Dermatology and Venereology;2024-01-26
2. An Overview of the EORTC-CLTG 2022 Congress;EMJ Oncology;2022-11-14
3. Care structure of patients with mycosis fungoides and Sézary syndrome in Germany – Care research based on SHI claims data;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-05
4. Versorgungsstruktur der Patienten mit Mycosis fungoides und Sézary‐Syndrom in Deutschland – Versorgungsforschung auf Basis von GKV‐Routinedaten;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-05
5. Two cases of generalized eruptive lentiginosis in cutaneous T‐cell lymphoma following mogamulizumab treatment;International Journal of Dermatology;2022-01-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3